Pfizer (PFE) Stock Price, Quote, News & History | Benzinga

Pfizer Inc (PFE) Stock Price, Quote, News & History

PFENYSE

Trade with Public

Trade with Public

$27.12

0.250.93%

Last update: Aug 18, 9:30 AM

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Dividends Compare Options Stock Report

Key Statistics

Open

$27.15

Close

-

Volume / Avg.

6.39M / 41.75M

Day Range

$27.12 - $27.40

52 Wk Range

23.58 - 28.75

Market Cap

$154.19B

P/E Ratio

35.36

Dividend Yield

6.40%

Exchange

NYSE

RSI

69

Short Interest

2.84%

Days to Cover

4.18

Recent Pfizer Inc. News

European Regulator Validates Pfizer and Valneva's Lyme Disease Vaccine Application

Valneva (VALN) stock surges after EMA validates MAA for Lyme disease vaccine candidate developed with Pfizer (PFE). Phase 3 trial showed efficacy and no safety concerns, pending regulatory approval.

Vandana Singh

Why Eton Pharmaceuticals Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket

Eton Pharmaceuticals Inc (NASDAQ: ETON) rose in pre-market trading after reporting strong Q2 results and issuing FY26 revenue guidance above estimates.

Avi Kapoor

Big Pharma's Future Growth Rests on Chinese Science? Expert Says: 'We Can't Ban Our Way Out of This'

China’s science surge is reshaping global drug development as Washington moves to counter Beijing’s growing influence in medicine.

Mohd Haider

Kathy Hochul Slams Trump Over Medicare Cut, Says 1.3 Million New Yorkers Will Pay More for Prescriptions: 'A New Assault on Seniors...'

Kathy Hochul says Trump's Medicare subsidy decision will raise prescription drug costs for 1.3 million New Yorkers.

Tanya Rawat

Dow Jumps Over 900 Points As Crude Oil Falls: Investor Sentiment Improves Further, Fear Index Moves To ‘Greed’ Zone

Market sentiment improves, Dow Jones jumps 900 points to record high. Crude oil prices fall on potential deal to reopen Strait of Hormuz.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

13.40B

Investing Cash Flow (TTM)

-5.69B

Financing Cash Flow (TTM)

-8.40B

Free Cash Flow (TTM)

10.99B

Capital Expenditure (TTM)

-2.42B

Net Change in Cash (TTM)

-682.00M

Analyst Trends and Forecast

1

4

1

Apr

0

0

0

0

Jun

2

3

Jul

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

2.6

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$204.65B

PE Ratio (TTM)

35.36

PE Ratio (FWD)

9.11

PEG Ratio (TTM)

2.60

PS Ratio (TTM)

2.42

PB Ratio (TTM)

1.80

Earnings Yield % (TTM)

2.83%

Earnings Yield % (FWD)

10.98%

EV / EBITDA (TTM)

15.17

Price / EBITDA (TTM)

11.40

Price / Free Cash Flow (TTM)

14.00

Book Value / Share

$14.95

Company Debt

Total Debt

$63.19B

LT Debt

$60.50B

LT Debt Issuance (TTM)

$5.99B

LT Debt Repayment (TTM)

-$4.26B

Total Cash

$976.00M

Debt to Equity

0.74

Issuance of Debt (TTM)

$1.73B

Repayment of Debt (TTM)

-$4.21B

Key Statistics

Open

$27.15

Close

-

Volume / Avg.

6.39M / 41.75M

Day Range

$27.12 - $27.40

52 Wk Range

23.58 - 28.75

Market Cap

$154.19B

P/E Ratio

35.36

Dividend Yield

6.40%

Exchange

NYSE

RSI

69

Short Interest

2.84%

Days to Cover

4.18

About

Sector

Health Care

Industry

Pharmaceuticals

Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. To...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Pfizer (PFE) stock?

A

You can purchase shares of Pfizer (NYSE:PFE) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Pfizer (PFE) competitors?

A

Other companies in Pfizer’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).

Q

What is the forecast, or price target, for Pfizer (PFE) stock?

A

Pfizer has a consensus price target of $29.82.

Q

What is the current price for Pfizer (PFE)?

A

The stock price for Pfizer (NYSE: PFE) is $27.12 last updated August 18, 2026 at 9:30 AM EDT.

Q

Does Pfizer (PFE) pay a dividend?

A

There are no upcoming dividends for Pfizer.

Q

When is Pfizer (NYSE:PFE) reporting earnings?

A

Pfizer does not have any upcoming earnings scheduled.

Q

Is Pfizer (PFE) going to split?

A

There is no upcoming split for Pfizer.

Q

What sector and industry does Pfizer (PFE) operate in?

A

Pfizer is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.